Vanguard Group’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Sell |
1,084,705
-133,940
| -11% | -$295K | ﹤0.01% | 3481 |
|
|
2025
Q1 | $2.63M | Sell |
1,218,645
-11,022
| -0.9% | -$23.8K | ﹤0.01% | 3395 |
|
|
2024
Q4 | $5.2M | Sell |
1,229,667
-43,848
| -3% | -$185K | ﹤0.01% | 3253 |
|
|
2024
Q3 | $14.6M | Buy |
1,273,515
+686,997
| +117% | +$7.86M | ﹤0.01% | 2762 |
|
|
2024
Q2 | $6.27M | Buy |
586,518
+50,186
| +9% | +$536K | ﹤0.01% | 3155 |
|
|
2024
Q1 | $8.23M | Buy |
+536,332
| New | +$8.23M | ﹤0.01% | 3068 |
|